Advertisement

Topics

Evotec Announces First Half Year 2017 Results and Corporate Update

02:10 EDT 10 Aug 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
- VERY STRONG OPERATIONAL AND FINANCIAL PERFORMANCE IN H1 2017 - IMPORTANT MILESTONE ACHIEVEMENTS - EXPANSION OF CUSTOMER BASE AND SIGNIFICANT NEW PARTNERSHIPS - ACQUISITION OF APTUIT TO EXPAND LEADERS...

Other Sources for this Article

Evotec AG
Gabriele Hansen, +49.(0)40.56081-255
VP Corporate Communications & Investor Relations
gabriele.hansen@evotec.com

NEXT ARTICLE

More From BioPortfolio on "Evotec Announces First Half Year 2017 Results and Corporate Update"

Quick Search
Advertisement
 

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...